UPDATE: Canaccord Genuity Upgrades AEterna Zentaris (AEZS) to Spec. Buy; Analyst Notes Removal of Dilution Overhang From Series B Warrants

Go back to UPDATE: Canaccord Genuity Upgrades AEterna Zentaris (AEZS) to Spec. Buy; Analyst Notes Removal of Dilution Overhang From Series B Warrants

Aeterna Zentaris (AEZS) Misses Q3 EPS by 1c

November 5, 2015 5:00 PM EST

Aeterna Zentaris (NASDAQ: AEZS) reported Q3 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $0 versus the consensus estimate of $450 thousand.

For earnings history and earnings-related data on Aeterna Zentaris (AEZS) click here.

... More